Hedgehog signaling pathway regulates human pancreatic cancer cell proliferation and metastasis

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 1124-1132

  Hao, Kun ^a   Tian, Xiao Dong ^a   Qin, Chang Fu ^a   Xie, Xue Hai ^a   Yang, Yin Mo ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Cancer stem cell; Epithelial mesenchymal transition; Hedgehog; Pancreatic cancer

Indexed keywords

CELL MARKER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STEM CELL; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE KNOCKDOWN TECHNIQUES; HEDGEHOG PROTEINS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBGINGIVAL CURETTAGE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84872803741     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2210     Document Type: Article

References (46)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Magee CJ, Ghaneh P and Neoptolemos JP: Surgical and medical therapy for pancreatic carcinoma. Best Pract Res Clin Gastroenterol 16: 435-455, 2002.
3. Yeo T P, Hruban RH, Leach SD, et al: Pancreatic cancer. Curr Probl Cancer 26: 176-275, 2002.
4. Warshaw AL and Fernández-del Castillo C: Pancreatic carcinoma. N Engl J Med 326: 455-465, 1992.
5. Koorstra JB, Hustinx SR, Offerhaus GJ and Maitra A: Pancreatic carcinogenesis. Pancreatology 8: 110-125, 2008. (Pubitemid 351670364)
6. Mueller MT, Hermann PC, Witthauer J, Rubio-Viqueira B, Leicht SF and Huber S: Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 137: 1102-1113, 2009.
7. -/low subpopulation and the side population of breast cancer cells. Anticancer Res 29: 2147-2157, 2009.
8. Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J and Srivastava RK: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 6: e16530, 2011.
9. Srivastava RK, Tang SN, Zhu W, Meeker D and Shankar S: Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. Front Biosci 3: 515-528, 2011.
10. Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331, 2004. (Pubitemid 39551660)
11. Ruiz i Altaba A, Mas C and Stecca B: The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol 17: 438-447, 2007. (Pubitemid 47505310)
12. Ruiz i Altaba A: Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? Cancer Cell 14: 281-283, 2008.
13. Bailey JM, Singh PK and Hollingsworth MA: Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem 102: 829-839, 2007. (Pubitemid 350036923)
14. Yang Y, Tian X, Xie X, Zhuang Y, Wu W and Wang W: Expression and regulation of hedgehog signaling pathway in pancreatic cancer. Langenbecks Arch Surg 395: 515-525, 2010.
15. Olive K P, Jacobetz MA, Davidson CJ, et al: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-1461, 2009.
16. Lee CJ, Dosch J and Simeone DM: Pancreatic cancer stem cells. J Clin Oncol 26: 2806-2812, 2008.
17. Tang SN, Fu J, Nall D, Rodova M, Shankar S and Srivastava RK: Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer 131: 30-40, 2012.
18. Yao J, An Y, Wie JS, et al: Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines. Swiss Med Wkly 141: w13208, 2011.
19. Strand MF, Wilson SR, Dembinski JL, et al: A novel synthetic smoothened antagonist transiently inhibits pancreatic adeno-carcinoma xenografts in a mouse model. PLoS One 6: e19904, 2011.
20. Nüsslein-Volhard C and Wieschaus E: Mutations affecting segment number and polarity in Drosophila. Nature 287: 795-801, 1980. (Pubitemid 11214475)
21. Hooper JE and Scott MP: Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6: 306-317, 2005. (Pubitemid 40516897)
22. Kalderon D: Transducing the hedgehog signal. Cell 103: 371-374, 2000.
23. Kayed H, Kleeff J, Osman T, Keleg S, Büchler MW and Friess H: Hedgehog signaling in the normal and diseased pancreas. Pancreas 32: 119-129, 2006.
24. Berman DM, Karhadkar SS, Maitra A, et al: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425: 846-851, 2003. (Pubitemid 37351469)
25. Kayed H, Kleeff J, Keleg S, et al: Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer. Int J Cancer 110: 668-676, 2004. (Pubitemid 38746024)
26. Thayer SP, di Magliano MP, Heiser PW, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856, 2003. (Pubitemid 37355945)
27. Gao J, Li Z, Chen Z, et al: Antisense Smo under the control of the PTCH1 promoter delivered by an adenoviral vector inhibits the growth of human pancreatic cancer. Gene Ther 13: 1587-1594, 2006. (Pubitemid 44688459)
28. Xu XF, Guo CY, Liu J, et al: Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J Carcinog 8: 13, 2009.
29. Yoo YA, Kang MH, Lee HJ, et al: Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 71: 7061-7070, 2011.
30. Buonamici S, Williams J, Morrissey M, et al: Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med 2: 51ra70, 2010.
31. Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA and Wu J: Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J Hepatol 55: 838-845, 2011.
32. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
33. Di Fiore R, Santulli A, Ferrante RD, et al: Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 219: 301-313, 2009.
34. + cancer stem cells in human solid tumours. PLoS One 3: e3469, 2008.
35. Mahller Y Y, Williams J P, Baird WH, et al: Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS One 4: e4235, 2009.
36. Pode-Shakked N, Metsuyanim S, Rom-Gross E, et al: Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population. J Cell Mol Med 13: 1792-1808, 2009.
37. Walter D, Satheesha S, Albrecht P, et al: CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS One 6: e19506, 2011.
38. Han YG, Spassky N, Romaguera-Ros M, Garcia-Verdugo JM, Aguilar A, Schneider-Maunoury S and Alvarez-Buylla A: Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells. Nat Neurosci 11: 277-284, 2008. (Pubitemid 351311806)
39. Singh BN, Fu J, Srivastava RK and Shankar S: Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One 6: e27306, 2011.
40. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW and Guba M: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007. (Pubitemid 47355323)
41. Dembinski JL and Krauss S: Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis 26: 611-623, 2009.
42. Feldmann G, Dhara S, Fendrich V, et al: Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67: 2187-2196, 2007. (Pubitemid 46424238)
43. Maitah MY, Ali S, Ahmad A, Gadgeel S and Sarkar FH: Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 6: e16068, 2011.
44. Liao X, Siu MK, Au CW, et al: Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30: 131-140, 2009.
45. Olmeda D, Jordá M, Peinado H, Fabra A and Cano A: Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 26: 1862-1874, 2007. (Pubitemid 46474642)
46. Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428, 2007. (Pubitemid 46809165)